Medical News

RSS

U-M dentistry agrees to use Interleukin's PST test for gum disease clinical study

University of Michigan School of Dentistry has signed an agreement with Interleukin Genetics Inc. to conduct what may be the largest clinical study to date using genetic testing to assess the risk for gum disease.

13 Aug 2010

Sandata announces acquisition of Medical Management Technology Group's customer base

Sandata Technologies, LLC, a leading nationwide provider of information technology solutions to the home healthcare and social services communities today announced the acquisition of all of the home healthcare agency contracts of Medical Management Technology Group, Inc. in connection with the settlement of a patent infringement lawsuit.

13 Aug 2010

Peter Rullan offers Pixel Perfect skin treatment on Pixel CO2 laser purchase

Founder of the Dermatology Institute, Peter Rullan, M.D., has expanded his practice and is now offering Pixel Perfect™ treatments to his patients with the purchase of the Pixel CO2 laser from Alma Lasers.

13 Aug 2010

BioSante second-quarter net loss increases to $10.8 million

BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2010.

13 Aug 2010

ARMC completes system-wide conversion to Masimo rainbow technology

Arrowhead Regional Medical Center (ARMC) in Colton, California, and Masimo, the inventor of Masimo rainbow Pulse CO-Oximetry, Masimo rainbow Acoustic Monitorin, and Masimo SET Measure-Through Motion and Low Perfusion pulse oximetry, today jointly announced the completion of ARMC's system-wide conversion to Masimo rainbow technology.

13 Aug 2010

CPF urges people to consider clinical trials for pulmonary fibrosis

The Coalition for Pulmonary Fibrosis (CPF) is urging the more than 128,000 people known to suffer from the deadly lung disease, pulmonary fibrosis (PF), to consider clinical trials, including two new ones funded by the National Institutes of Health (NIH). Clinical trials of potential drug therapies are critical to the discovery of treatments for any disease and for a disease like PF that claims as many lives each year as breast cancer with virtually no survivors, they are the likely path to answers and saved lives.

13 Aug 2010

Severe inflammatory response to initial UTI causes bladder damage: Research

The immune system may open the door to recurrent urinary tract infections (UTIs) by overdoing its response to an initial infection, researchers at Washington University School of Medicine in St. Louis have found.Researchers showed in mice that severe inflammatory responses to an initial UTI cause bladder damage and allow infection to persist longer. After one to two weeks of infection, the bladder wall undergoes additional changes that leave mice more vulnerable to later infection. Suppressing the immune system during initial infection decreases these vulnerabilities, they report Aug. 12 in PLoS Pathogens.

13 Aug 2010

Mass. docs will soon track patients who abuse prescription drugs; Wis. Catholic Church employees now eligible for birth control

The Boston Globe: "With a few computer keystrokes, Massachusetts physicians will soon be able to identify patients who travel from clinic to clinic in pursuit of potent prescription drugs that feed lethal addictions. State health regulators yesterday unanimously approved the new detection system designed to stop 'doctor shopping' by addicted patients who try to dupe doctors into prescribing narcotics. The practice, specialists said, has fueled a surge in drug-related deaths in Massachusetts" (Smith, 8/12).

13 Aug 2010

Exposure to immune proteins during pregnancy increases risk for schizophrenia in offspring

Infections like the flu are common occurrences during pregnancy, and research has shown that children born to mothers who suffered from flu, viruses and other infections during pregnancy have about a 1.5 to 7 times increased risk for schizophrenia. A new study out of Temple University examines what's behind that link.

13 Aug 2010

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

Clearstone Central Laboratories, a leading provider of central laboratory services for late-stage clinical trials, announced today a global collaboration with Laboratory Corporation of America® Holdings through its Esoterix Clinical Trials Services division, providing clients with seamless access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.

13 Aug 2010

Trimeris second-quarter royalty revenue decreases to $1.6 million

Trimeris, Inc., or the "Company," today announced financial results for the quarter ended June 30, 2010, reporting net income of $1.3 million, or $0.06 per share, which was unchanged from the quarter ended June 30, 2009. Comparisons of net income between the quarters ended June 30, 2010 and June 30, 2009 are affected by a one-time adjustment in the second quarter of 2009 that increased operating expenses for that period by $496,000.

13 Aug 2010

New criteria by ACR for early diagnosis, treatment of rheumatoid arthritis

New criteria for rheumatoid arthritis (RA), published in the Annals of Rheumatic Diseases, could prevent thousands of people from developing disabling late stage disease, by redefining how RA should be classified.Rheumatoid arthritis is a progressive autoimmune inflammatory disease, primarily of the joints. If untreated, it leads to damage of bone and cartilage, joint deformities and disability. Around 350,000 people in the UK are living with RA, which affects around three times as many women as men.

13 Aug 2010

HIV infected injection drug users likely to have kidney disease: Study

Poor kidney function is common among injection drug users, particularly those with HIV, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that clinicians should monitor the kidney function of HIV-infected injection drug users and consider them candidates for medical treatments to protect their kidneys when appropriate.

13 Aug 2010

The Australian examines development of low-cost water purifiers by Indian companies

The Australian reports on how four large businesses in India are developing low-cost water purifiers for some of the country's "poorest of the poor."

13 Aug 2010

Novavax announces positive results from pre-clinical toxicology study of RSV vaccine candidate

Novavax, Inc. reported today that results from a pre-clinical toxicology study of its vaccine candidate to prevent respiratory syncytial virus, showed the vaccine to be safe and well-tolerated at all doses tested. Novavax's vaccine uses highly purified recombinant particles of RSV-F fusion protein normally found in the virus. There is currently no approved vaccine to prevent RSV infection.

13 Aug 2010

Education and screening of pregnant women recommended for prevention of Fetal Alcohol Spectrum Disorder

Featured in the August edition of the Journal of Obstetrics and Gynaecology Canada is a new consensus clinical practice guideline which recommends that screening for alcohol consumption be done periodically for all pregnant women and women of child-bearing age.

13 Aug 2010

PyroTITAN Humeral Resurfacing shoulder implant extends longevity of hemiarthroplasty joint replacement

Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of an additional PyroTITAN Humeral Resurfacing Implant in Brisbane, Australia. The PyroTITAN was implanted last month at the Brisbane Private Hospital.

13 Aug 2010

Akela reports $0.1M net income for second-quarter 2010 vs. $1.1M net loss for same period in 2009

Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three and six months ended June 30, 2010.

13 Aug 2010

Study examines impact of microvascular decompression surgery for type 2 diabetes

A team of Allegheny General Hospital (AGH) physicians led by neurosurgical pioneer Peter Jannetta, MD, has made an important new discovery linking the central nervous system to the onset and progression of type 2 diabetes mellitus.Reporting today in the journal Surgical Neurology International, Dr. Jannetta and his colleagues present evidence from a prospective clinical trial that vascular compression of a section of the brain called the medulla oblongata is a factor in some patients with type 2 diabetes and that microvascular decompression surgery (MVD) may be an effective treatment for the condition.

13 Aug 2010

Prices drop for PBMs; Pharmacy lobby opposes survey regarding Medicaid prices

Prices are falling for major pharmacy benefit managers, such as Medco and CVS Caremark, as the firms compete for clients, but the falling rates "don't appear to be sliding into a frenzy of unreasonable pricing," The Wall Street Journal reports. "In the current 'selling season,' when PBMs look to sign customers for the following year, discounts on new contracts have deepened by one or two percentage points, on average, from a year ago.

13 Aug 2010

Medical News

U-M dentistry agrees to use Interleukin's PST test for gum disease clinical study

Sandata announces acquisition of Medical Management Technology Group's customer base

Peter Rullan offers Pixel Perfect skin treatment on Pixel CO2 laser purchase

BioSante second-quarter net loss increases to $10.8 million

ARMC completes system-wide conversion to Masimo rainbow technology

CPF urges people to consider clinical trials for pulmonary fibrosis

Severe inflammatory response to initial UTI causes bladder damage: Research

Mass. docs will soon track patients who abuse prescription drugs; Wis. Catholic Church employees now eligible for birth control

Exposure to immune proteins during pregnancy increases risk for schizophrenia in offspring

Clearstone Central Laboratories announces strategic global collaboration with LabCorp

Trimeris second-quarter royalty revenue decreases to $1.6 million

New criteria by ACR for early diagnosis, treatment of rheumatoid arthritis

HIV infected injection drug users likely to have kidney disease: Study

The Australian examines development of low-cost water purifiers by Indian companies

Novavax announces positive results from pre-clinical toxicology study of RSV vaccine candidate

Education and screening of pregnant women recommended for prevention of Fetal Alcohol Spectrum Disorder

PyroTITAN Humeral Resurfacing shoulder implant extends longevity of hemiarthroplasty joint replacement

Akela reports $0.1M net income for second-quarter 2010 vs. $1.1M net loss for same period in 2009

Study examines impact of microvascular decompression surgery for type 2 diabetes

Prices drop for PBMs; Pharmacy lobby opposes survey regarding Medicaid prices

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News